Overview

Radiation and TSR-042 in People With Endometrial Cancer After They Receive Surgery

Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This study will test whether the combination of radiation and TSR-042 is an effective treatment for women with MMR-D/MSI-H endometrial cancer who have recently undergone surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborator:
Tesaro, Inc.